302 related articles for article (PubMed ID: 26430882)
1. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy.
McCausland MR; Juchnowski SM; Zidar DA; Kuritzkes DR; Andrade A; Sieg SF; Lederman MM; Funderburg NT
PLoS One; 2015; 10(10):e0139474. PubMed ID: 26430882
[TBL] [Abstract][Full Text] [Related]
2. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
Serrano-Villar S; Sainz T; Ma ZM; Utay NS; Chun TW; Mann S; Kashuba AD; Siewe B; Albanese A; Troia-Cancio P; Sinclair E; Somasunderam A; Yotter T; Deeks SG; Landay A; Pollard RB; Miller CJ; Moreno S; Asmuth DM
PLoS Pathog; 2016 Jan; 12(1):e1005381. PubMed ID: 26795282
[TBL] [Abstract][Full Text] [Related]
3. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
[TBL] [Abstract][Full Text] [Related]
5. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
6. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
[TBL] [Abstract][Full Text] [Related]
7. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
Kelesidis T; Tran TT; Stein JH; Brown TT; Moser C; Ribaudo HJ; Dube MP; Murphy R; Yang OO; Currier JS; McComsey GA
Clin Infect Dis; 2015 Aug; 61(4):651-60. PubMed ID: 25904376
[TBL] [Abstract][Full Text] [Related]
8. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.
Tuluc F; Spitsin S; Tustin NB; Murray JB; Tustin R; Schankel LA; Wiznia A; Nachman S; Douglas SD
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):133-142. PubMed ID: 27615375
[TBL] [Abstract][Full Text] [Related]
9. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
[TBL] [Abstract][Full Text] [Related]
10. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
11. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
[TBL] [Abstract][Full Text] [Related]
12. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
[TBL] [Abstract][Full Text] [Related]
13. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
Front Immunol; 2021; 12():738743. PubMed ID: 34630420
[TBL] [Abstract][Full Text] [Related]
14. Sources of heterogeneity in human monocyte subsets.
Appleby LJ; Nausch N; Midzi N; Mduluza T; Allen JE; Mutapi F
Immunol Lett; 2013 Apr; 152(1):32-41. PubMed ID: 23557598
[TBL] [Abstract][Full Text] [Related]
15. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease.
Grip O; Bredberg A; Lindgren S; Henriksson G
Inflamm Bowel Dis; 2007 May; 13(5):566-72. PubMed ID: 17260384
[TBL] [Abstract][Full Text] [Related]
16. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P
Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
[TBL] [Abstract][Full Text] [Related]
19. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
